|Day Low/High||37.16 / 37.66|
|52 Wk Low/High||33.88 / 64.50|
When the cat's away, the (retail) mice will play.
No one knows where the giant squid is going to strike next.
It may be due for a pullback, and the company could feel the effects of Amazon.
A selloff in tech stocks regained momentum, pulling the Nasdaq lower for the day and wiping out the index's monthly gain.
This deal looks like to be wrapped up soon.
Wall Street kicked off the final week of the first half of the year with a mixed end.
It is hard to tell if $76 will be broken, but honestly, it does not look like strong support.
If this is a bear market, why do the buyers keep showing up?
Kroger call is the latest sign that it's a jungle out there.
A record close for the Nasdaq was looking likely until a swift selloff in tech dragged the index from its heights.
The CEOs of Rite Aid and Walgreens issued memos to employees addressing delays and uncertainty from the FTC.
Hurry up and get that ticket to Washington, DC.
Stocks end at session lows as an earnings disappointment from IBM weighs on the Dow Jones Industrial Average and a crude selloff pressures the energy sector.
Stocks end lower as the latest Federal Reserve meeting minutes show a central bank committed to monetary tightening.
On Wednesday, April 5, investors await quarterly earnings from Walgreens WBA, Bed Bath & Beyond BBBY and Monsanto MON.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer discusses Tuesday's trending stocks including Tesla TSLA, Ford F, Caterpillar CAT, President Trump's meeting with CEOs and Walgreens WBA.
TheStreet's Jim Cramer said he wants the Walgreens Boots Alliance WBA merger with Rite Aid RAD deal to close or fall apart soon.
Jim Cramer discusses Friday's trending stocks, including Apple, Lululemon, Arconic and Walgreens Boots Alliance.
TheStreet's Jim Cramer wants the Walgreens Boots Alliance and Rite Aid merger to close. Walgreens is a holding of Cramer's charitable trust, Action Alerts PLUS.
Walgreens has been waiting for approval for its $9.7 billion bid for Rite Aid since 2014.
These four blue chips look primed to lead the S&P higher this spring.
If you're waiting for positive quarterly comparisons, you'll miss the opportunity.
Research firm Credit Suisse has put together a list of 140 "top ideas" covered by their analysts.